Prior Glucose-Lowering Medication Use and 30-Day Outcomes Among 64,892 Veterans With Diabetes and COVID-19.

Pandora L WanderElliott LowyLauren A BesteLuis Tulloch-PalominoAnna KorpakAlexander C PetersonSteven E KahnEdward J Boyko

Published in: Diabetes care (2021)

Among veterans with diabetes and COVID-19, higher HbA1c and insulin use were directly associated with adverse outcomes, while use of a GLP1-RA, metformin, and SGLT2i was inversely associated.

Keyphrases

type diabetes
coronavirus disease
glycemic control
sars cov
cardiovascular disease
blood glucose
rheumatoid arthritis
respiratory syndrome coronavirus
metabolic syndrome
insulin resistance
ankylosing spondylitis
disease activity
weight loss
skeletal muscle